“GC Partners…are proactive, well connected and importantly, offer timely service. Their professionalism and follow through work is excellent. We recently raised through GC Partners introduction over £3.8 million in pre IPO funding…I am pleased to recommend GC Partners for firms seeking AIM admissions as they have a broad knowledge of this market and they strive to recommend the best solutions including minimising client admission process costs.…”
Chairman & CEO,
ACC plc
“EskiZara’s recommendation of GC Partners is based on their professionalism, integrity and most importantly, their ability to deliver results.”
Chairman & CEO
EskiZara OOD
“The company’s professionalism & competence over our 12 month engagement mandate was an unparalleled success. Their structured approach and disciplined process allowed us to establish a solid base of business in Australia & New Zealand…”
Co-founder, Shareholder & EVP,
Asia Online, Ltd.
“The company did a great job for us in Australia. They are extremely hard-working, productive and deliver results…”
President & Shareholder,
iAsiaWorks, Inc.
"The Company moved quickly to establish a series of meetings in Taiwan, Hong Kong and Singapore with a number of pre-qualified institutional investors, strategic partners and investment banks interested in our USD20m fund raising. The company's senior executives accompanied us to all meetings and their staff co-ordinated follow up calls and gave us regular feed back on potential investor deliberations. The company approached our assignment with professionalism, energy and enthusiasm......"
Managing Director,
Pi2 Limited
“We treat approaches from the company very seriously. The company does an excellent job in preparing potential investees to present to us. The company's management understands the Venture capital business and what Venture Capitalists are looking for"......
Investment Director,
Hambro Grantham Management Limited
"...Biotech Australia has recently been associated with The company’s management in a capital raising program. Biotech Australia was an acquisition target and worked with the company in making presentations on the business of Biotech Australia to potential institutional and high net worth investors in Singapore, Hong Kong and Taipei.
We found the company’s team to be very professional, well briefed with excellentresearch resources, focused and verytenacious. The preparation for the'road show' was extensive, the research on targeted investment groupscomprehensive, and all potential investors were well briefed prior tomeeting. Biotech Australia was given excellentadvice and support by the company’sstaff in preparing its presentation. Biotech Australia would have no hesitation in engaging the company for corporate advisory work.”